Form 4 for EOG EOG Resources
Accepted 2022-03-07 00:00:00 ET · period of report 2022-03-04 · accession 0001127602-22-008335 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-07 | 2022-03-04 | EOG | Boedeker Kenneth W. | EVP Exploration, Production | M - OptEx | $37.44 | +2,118 | 19.4K | +12% | +$79.3K |
| D | 2022-03-07 | 2022-03-04 | EOG | Boedeker Kenneth W. | EVP Exploration, Production | S - Sale+OE | $120.14 | -1,102 | 17.3K | -6% | -$132.4K |
| D | 2022-03-07 | 2022-03-04 | EOG | Boedeker Kenneth W. | EVP Exploration, Production | F - Tax | $120.15 | -356 | 18.4K | -2% | -$42.8K |
| D | 2022-03-07 | 2022-03-04 | EOG | Boedeker Kenneth W. | EVP Exploration, Production | D - Sale to Iss | $120.15 | -660 | 18.7K | -3% | -$79.3K |
| D | 2022-03-07 | 2022-03-04 | EOG | Boedeker Kenneth W. | EVP Exploration, Production | M - OptEx | $0.00 | -2,118 | 4,244 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-04 | M | A | 2,118 | $37.44 | 19,404 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-04 | S | D | 1,102 | $120.14 | 17,286 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-04 | F | D | 356 | $120.15 | 18,388 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-04 | D | D | 660 | $120.15 | 18,744 | D | — | — | |
| 5 | Derivative | Stock Appreciation Rights | 2022-03-04 | M | D | 2,118 | $0.00 | 4,244 | D | $37.44 · 2021-09-28 to 2027-09-28 | 2,118 Common Stock | (F1) The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. |